Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab

PURPOSE: To report on two cases of treatment-refractory juxtapapillary hemagioblastomas that were managed with intra-arterial bevacizumab delivered via the ophthalmic artery. OBSERVATIONS: Case 1 is a 35 year-old man with juxtapapillary hemangioblastoma who continued to have progressive tractional r...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Jasmine H., Slakter, Jason S., Abramson, David H., Odrich, Steven A., Gobin, Y. Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026768/
https://www.ncbi.nlm.nih.gov/pubmed/29978140
http://dx.doi.org/10.1016/j.ajoc.2018.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026768/
https://www.ncbi.nlm.nih.gov/pubmed/29978140
http://dx.doi.org/10.1016/j.ajoc.2018.05.007

Ejemplares similares